Log in

NYSE:XANExantas Capital Stock Price, Forecast & News

+0.15 (+7.25 %)
(As of 06/3/2020 04:00 PM ET)
Today's Range
Now: $2.22
50-Day Range
MA: $2.39
52-Week Range
Now: $2.22
Volume1.84 million shs
Average Volume1.13 million shs
Market Capitalization$71.13 million
P/E RatioN/A
Dividend YieldN/A
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.
Read More
Exantas Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.08 out of 5 stars

Industry, Sector and Symbol

Industry Real estate investment trusts



Sales & Book Value

Annual Sales$61.15 million
Cash Flow$1.56 per share
Book Value$17.45 per share


Net Income$35.97 million
Net Margins-274.26%


Market Cap$71.13 million
Next Earnings Date7/29/2020 (Estimated)

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

Exantas Capital (NYSE:XAN) Frequently Asked Questions

How has Exantas Capital's stock been impacted by COVID-19 (Coronavirus)?

Exantas Capital's stock was trading at $9.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XAN stock has decreased by 77.2% and is now trading at $2.22. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exantas Capital?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exantas Capital.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Exantas Capital.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) posted its earnings results on Thursday, May, 7th. The company reported $0.23 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.30 by $0.07. The company had revenue of $14.90 million for the quarter. Exantas Capital had a negative net margin of 274.26% and a positive return on equity of 7.95%. View Exantas Capital's earnings history.

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital announced a quarterly dividend on Friday, March 13th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.275 per share on Tuesday, April 28th. This represents a $1.10 dividend on an annualized basis and a dividend yield of 49.55%. The ex-dividend date is Monday, March 30th. View Exantas Capital's dividend history.

What price target have analysts set for XAN?

2 brokerages have issued 1-year target prices for Exantas Capital's stock. Their forecasts range from $4.00 to $4.00. On average, they expect Exantas Capital's share price to reach $4.00 in the next year. This suggests a possible upside of 80.2% from the stock's current price. View analysts' price targets for Exantas Capital.

Has Exantas Capital been receiving favorable news coverage?

Media headlines about XAN stock have been trending very negative on Thursday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Exantas Capital earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutExantas Capital.

Are investors shorting Exantas Capital?

Exantas Capital saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,690,000 shares, an increase of 111.8% from the April 30th total of 1,270,000 shares. Based on an average daily volume of 1,410,000 shares, the short-interest ratio is currently 1.9 days. Currently, 8.7% of the company's shares are sold short. View Exantas Capital's Current Options Chain.

Who are some of Exantas Capital's key competitors?

What other stocks do shareholders of Exantas Capital own?

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the following people:
  • Mr. Robert C. Lieber, Chief Exec. Officer (Age 65)
  • Mr. Matthew J. Stern, Pres (Age 45)
  • Mr. David J. Bryant, Sr. VP, CFO & Treasurer (Age 61)
  • Mr. Thomas C. Elliott, Exec. VP of Fin. & Operations (Age 46)
  • Mr. Eldron C. Blackwell, VP & Chief Accounting Officer (Age 40)

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

Who are Exantas Capital's major shareholders?

Exantas Capital's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.83%), HBK Investments L P (4.89%), State Street Corp (3.68%), Wolverine Asset Management LLC (2.12%), Bayview Asset Management LLC (1.97%) and Acadian Asset Management LLC (1.11%). Company insiders that own Exantas Capital stock include David J Bryant, Robert C Lieber, Stephanie H Wiggins and Thomas C Elliott. View institutional ownership trends for Exantas Capital.

Which institutional investors are selling Exantas Capital stock?

XAN stock was sold by a variety of institutional investors in the last quarter, including HBK Investments L P, Bayview Asset Management LLC, Parametric Portfolio Associates LLC, Martingale Asset Management L P, Morgan Stanley, BlackRock Inc., Wells Fargo & Company MN, and Mackenzie Financial Corp. View insider buying and selling activity for Exantas Capital.

Which institutional investors are buying Exantas Capital stock?

XAN stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Wolverine Asset Management LLC, Advisor Group Holdings Inc., WINTON GROUP Ltd, Two Sigma Advisers LP, Los Angeles Capital Management & Equity Research Inc., Aigen Investment Management LP, and Mackay Shields LLC. Company insiders that have bought Exantas Capital stock in the last two years include David J Bryant, Robert C Lieber, and Thomas C Elliott. View insider buying and selling activity for Exantas Capital.

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $2.22.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $71.13 million and generates $61.15 million in revenue each year. The company earns $35.97 million in net income (profit) each year or $1.00 on an earnings per share basis.

What is Exantas Capital's official website?

The official website for Exantas Capital is www.exantas.com.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.